WINDOW THERAPEUTICS, INC.
Powering the development of breakthrough therapies
BOSTON, United States · Founded 2022 · $1.6M raised
- Headquarters
- BOSTON, Massachusetts
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- windowtx.com
- Total Funding
- $1.6M
About
Window Therapeutics is a Boston-based biopharmaceutical company discovering and developing transformational therapeutics for cancer and other life-threatening diseases. The company's proprietary BAM (Bottle-brush-Analogue-Macromonomer) technology platform, derived from over a decade of research at MIT, enables next-generation antibody-drug conjugates (ADCs) and polymer-based therapeutics with applications across oncology, fibrosis, autoimmune, and infectious disease areas.
Summary
WINDOW THERAPEUTICS, INC. is a Biotech company based in BOSTON, United States, founded in 2022. It has raised $1.6M in total.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...